About Univ8
Our Purpose
Aenean eu leo quam. Pellentesque ornare sem lacinia quam venenatis vestibulum. Maecenas faucibus mollis interdum. Nullam quis risus eget urna mollis ornare vel eu leo. Cum sociis natoque.
The EuroClonality-NDC is a capture-based targeted next generation sequencing (NGS) assay with customised bioinformatics pipeline for research use only, designed and developed by the EuroClonality-NGS working group (an independent subdivision of EuroClonality).
The EuroClonality-NDC assay has undergone a large multi-centre validation, performed across seven European laboratories, in a wide range of samples from more than 15 categories of lymphoid malignancies and including high molecular weight (HMW) and FFPE gDNA.
A Global Partnership
Aenean eu leo quam. Pellentesque ornare sem lacinia quam venenatis vestibulum. Maecenas faucibus mollis interdum. Nullam quis risus eget urna mollis ornare vel eu leo. Cum sociis natoque.
The EuroClonality-NDC is a capture-based targeted next generation sequencing (NGS) assay with customised bioinformatics pipeline for research use only, designed and developed by the EuroClonality-NGS working group (an independent subdivision of EuroClonality).
The EuroClonality-NDC assay has undergone a large multi-centre validation, performed across seven European laboratories, in a wide range of samples from more than 15 categories of lymphoid malignancies and including high molecular weight (HMW) and FFPE gDNA.
Section Subheading
Section Heading
Cras justo odio, dapibus ac facilisis in, egestas eget quam. Vestibulum id ligula porta felis euismod semper. Aenean lacinia bibendum nulla sed consectetur. Praesent commodo cursus magna, vel scelerisque nisl consectetur et. Donec ullamcorper nulla non metus auctor fringilla. Nullam id dolor id nibh ultricies vehicula ut id elit.
Donec sed odio dui. Aenean eu leo quam. Pellentesque ornare sem lacinia quam venenatis vestibulum. Nullam id dolor id nibh ultricies vehicula ut id elit. Maecenas sed diam eget risus varius blandit sit amet non magna. Sed posuere consectetur est at lobortis. Morbi leo risus, porta ac consectetur ac, vestibulum at eros.